DLA Piper advised Dye & Durham on the deal. Dye & Durham, a leading provider of legal software, payments and banking infrastructure, closed its previously announced ?private...
You must be a Standard 1 Year member to access this content.
Paul Hastings LLP advised Jasper Therapeutics, Inc., while DLA Piper advised the underwriters. Jasper Therapeutics, Inc. (Nasdaq: JSPR), a clinical-stage biotechnology company focused on developing novel...
You must be a Standard 1 Year member to access this content.
Shearman & Sterling advised CVS Health, while Simpson Thacher advised the underwriters led by Barclays Capital Inc., BofA Securities, Inc. and J.P. Morgan Securities LLC, on...
You must be a Standard 1 Year member to access this content.
Shearman & Sterling advised CVS Health, while Simpson Thacher advised Barclays, Goldman Sachs and Wells Fargo Securities, LLC as dealer managers, on the deal. CVS Health...
You must be a Standard 1 Year member to access this content.
Shearman & Sterling advised the underwriters in the offering. Caribou Biosciences, Inc. executed its initial public offering of 19 million shares of common stock at a public...
You must be a Standard 1 Year member to access this content.
Cravath represented Genpact Luxembourg S.à r.l. and Genpact USA, Inc., while Shearman & Sterling represented the underwriters in the offering. Genpact Luxembourg S.à r.l. and Genpact...
You must be a Standard 1 Year member to access this content.
Shearman & Sterling advised the underwriters in the offering. Mazanti advised Y-mAbs Therapeutics.r Y-mAbs Therapeutics, Inc. executed its 2,804,878 shares of common stock at a public offering...
You must be a Standard 1 Year member to access this content.
